CSL Bulk Human Coagulation Factor VIII 250 IU / von Willebrand factor 600 IU powder for injection vial

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

Von willebrand factor, Quantity: 600 IU; Factor VIII, Quantity: 250 IU

Saadav alates:

CSL Behring Australia Pty Ltd

INN (Rahvusvaheline Nimetus):

Factor VIII,Von willebrand factor

Ravimvorm:

Injection, powder for

Koostis:

Excipient Ingredients: calcium chloride dihydrate; sodium chloride; trometamol; sucrose; Albumin; sodium citrate dihydrate

Manustamisviis:

Intravenous

Näidustused:

von Willebrand disease (VWD) - Treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital FVIII deficiency) - Prophylaxis and treatment of bleeding in patients with haemophilia A.

Toote kokkuvõte:

Visual Identification: A white or pale yellow, hygroscopic powder or friable solid; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2013-09-02